Progressive Retinal Degeneration in Dogs (Progressive Retinal Atrophy, PRA)
- Occurrence: very rare
- Location of disease: Head/Neck
When to visit the vet?
Non-urgent see a veterinarian within 2–3 days
If the condition worsens / symptoms persist, consult a veterinarian.
Definition
Progressive Retinal Atrophy (PRA) is a hereditary eye disease in dogs that causes progressive degeneration of the retina, ultimately leading to blindness.
Das Wichtigste auf einen Blick
Progressive Retinal Atrophy (PRA) is a genetic eye disease in dogs where the light-sensitive cells of the retina, particularly the photoreceptors (rods and cones), degenerate. This degeneration leads to a progressive deterioration of vision and can ultimately result in blindness. PRA is caused by various genetic mutations that can be inherited from parents. Certain breeds such as Labrador Retrievers, Poodles, and Cocker Spaniels are more commonly affected. Symptoms include night blindness, dilated pupils, and impaired vision. Diagnosis is made through eye examinations, electroretinograms, and genetic tests to identify specific mutations.
There is currently no cure for PRA, but lifestyle changes and nutritional supplements can improve the quality of life of affected dogs. A safe environment with fixed furniture placement can help better cope with vision loss. Since PRA is incurable, responsible breeding practices are crucial to prevent the spread of the disease. Research is focusing on gene therapy, stem cell therapy, and new medications to slow retinal degeneration. Advances in imaging and genetic testing could make it possible to diagnose PRA early and preserve vision. Although many approaches are still being researched, there is hope that future advances could open up new treatment options.
Ursachen
The retina is the light-sensitive tissue at the back of the eye that converts light into nerve impulses sent to the brain. In PRA, the light-sensitive cells of the retina, particularly the photoreceptors, which include rods and cones, degenerate. These cells are responsible for vision in low light conditions and color vision. The degeneration leads to a progressive deterioration of vision.
The causes of PRA are genetic. Various genetic mutations are associated with different forms of PRA, and these mutations can be inherited from one or both parents. The disease can be inherited in an autosomal dominant, autosomal recessive, or X-linked manner, depending on the specific genetic mutation and dog breed.
Since PRA is genetic, certain breeds are more commonly affected, including Labrador Retrievers, Poodles, Cocker Spaniels, and Yorkshire Terriers. The genetic mutations that lead to PRA affect the normal function of photoreceptors, resulting in their degeneration and loss of vision.
Symptoms
The earliest symptom of PRA is night blindness. Affected dogs have difficulty navigating in dimly lit or dark environments. This symptom can occur in dogs of different ages, depending on the form of PRA and the breed.
As the disease progresses, dogs show a general deterioration of vision, ultimately leading to complete blindness. Other symptoms may include cloudy or enlarged pupils, and sometimes a reflection or shine may be noticed in the eyes when light falls on them.
Since the loss of vision occurs gradually, many dogs adapt well to their limited sight, which can make it difficult for owners to notice visual disturbances early on.
Diagnose
The diagnosis of PRA begins with a thorough eye examination by a veterinarian or a specialized veterinary ophthalmologist. An ophthalmoscope is used to assess the condition of the retina and detect signs of degeneration.
An electroretinogram (ERG) can be used to measure the electrical activity of the retina and determine if the photoreceptors are functioning properly. In dogs with PRA, the ERG shows reduced or absent activity of the retinal cells.
Genetic tests are also available to identify specific mutations associated with PRA. These tests are particularly useful for identifying carriers of PRA who show no symptoms but could pass the disease on to their offspring.
Therapie
There is currently no cure for PRA, and treatment options are limited. The focus is on improving the quality of life of the affected dog and helping them adapt to vision loss.
Changes in feeding and living arrangements can help the dog adapt to its new circumstances. A consistent environment with fixed furniture arrangements and safe areas can be helpful. Some owners also use scent markers to guide the dog through its home.
In some cases, nutritional supplements containing antioxidants like vitamin E and C can help support retinal health, although this treatment cannot stop the progression of the disease.
Prognose und Nachsorge
The prognosis for dogs with PRA varies depending on the stage of the disease and the type of PRA. Since the disease is progressive and incurable, it ultimately leads to blindness. However, many dogs cope well with their vision loss as long as they live in a safe and supportive environment.
The timing of complete vision loss can vary depending on the breed and individual predisposition. Some dogs may go blind within a few months, while others may take years.
Prävention
The most important measure for the prevention of PRA is responsible breeding practices. Dogs that are carriers or affected should not be used for breeding. Genetic tests can help breeders identify carriers and reduce the spread of the disease.
Owners should inquire about the parents when choosing a puppy and ensure that they have been genetically tested to rule out the risk of PRA.
For dogs already affected, it is important to conduct regular veterinary examinations to monitor the progression of the disease and ensure the best possible quality of life.
Ausblick auf aktuelle Forschung
Research on progressive retinal atrophy (PRA) in dogs is a dynamic field that continuously provides new insights. PRA is a genetic eye disease that occurs in many dog breeds and leads to progressive deterioration of the retina. This can ultimately lead to complete blindness. An important research focus is on identifying gene mutations responsible for PRA. By identifying specific genetic markers, breeders can be better informed to minimize the risk of passing on this disease.
Another area of research focuses on the development of gene therapies. These therapies aim to repair or replace defective genes that cause PRA. There are already some promising studies showing that gene therapy could slow or even stop the progression of the disease. However, such approaches are still being tested and are not currently widely available. Research in this area is very active and could soon offer new treatment options.
In addition to gene therapy, stem cell therapy is being investigated as a potential treatment method. Stem cells can transform into different cell types, and it is hoped that they can contribute to the regeneration of the damaged retina. This research is still in an early stage but shows potential, especially in combination with other therapies.
Another exciting area is the research into medications that can slow the progression of PRA. These medications could delay retinal degeneration and help affected dogs see longer. However, there are currently no specific medications approved for PRA, and many potential treatments are still in the experimental phase.
Research on early detection of PRA is also of great importance. Advances in imaging technology and genetic testing could make it possible to diagnose PRA at a very early stage, before clinical symptoms appear. This could be crucial for both prevention and treatment, as early intervention offers the best chances of preserving vision.
In summary, research on PRA in dogs is a highly active and interdisciplinary field. From genetics to cell therapy to new medications, there are many approaches being explored to combat this devastating disease. Although many of these research efforts are still in the early stages, there is justified hope that future advances could offer new, effective treatment options to significantly improve the lives of dogs with PRA.
Frequently Asked Questions (FAQs)
1. What is progressive retinal atrophy (PRA)?
2. Which dog breeds are most commonly affected by PRA?
3. How is PRA diagnosed?
4. Can dogs with PRA be treated?
5. Is PRA painful for dogs?
6. Can PRA be prevented in dogs?
7. What are the first signs of PRA in dogs?
8. How can I help my dog cope with PRA?
9. Are all forms of PRA the same?
10. Are there alternative healing methods for PRA?
Literatur
- Dufour, V. L., & Aguirre, G. D. (2025). Canine models of inherited retinal diseases: From neglect to well-recognized translational value. Mammalian Genome, 36, 500–510. https://doi.org/10.1007/s00335-024-10091-y
- Miyadera, K., Acland, G. M., & Aguirre, G. D. (2012). Genetic and phenotypic variations of inherited retinal diseases in dogs: The power of within- and across-breed studies. Mammalian Genome, 23(1–2), 40–61. https://doi.org/10.1007/s00335-011-9361-3
- Palanova, A. (2016). The genetics of inherited retinal disorders in dogs: Implications for diagnosis and management. Veterinary Medicine: Research and Reports, 7, 41–51. https://doi.org/10.2147/VMRR.S63537
- Petersen-Jones, S. M. (1998). A review of research to elucidate the causes of the generalized progressive retinal atrophies. The Veterinary Journal, 155(1), 5–18. https://doi.org/10.1016/S1090-0233(98)80028-2
- Freitas, H. M., Somma, A. T., Moore, B. A., & Montiani-Ferreira, F. (2021). Retrospective and prospective study of progressive retinal atrophy in dogs presented to the veterinary hospital of the Federal University of Paraná, Brazil. Open Veterinary Journal, 11(3), 370–378. https://doi.org/10.5455/OVJ.2021.v11.i3.6